Wei Li

Jilin University (JLU) - First Affiliated Hospital

71 Xinmin Street

Changchun , Jilin 130021

China

SCHOLARLY PAPERS

2

DOWNLOADS

70

SSRN CITATIONS

1

CROSSREF CITATIONS

0

Scholarly Papers (2)

1.

Pyrotinib or Lapatinib Combined with Capecitabine in Women with HER2-Positive Metastatic Breast Cancer Previously Treated with Taxanes, Anthracyclines, And/Or Trastuzumab: An Open-Label, Randomised, Phase 2 Study

Number of pages: 111 Posted: 22 Nov 2018
Chinese Academy of Medical Sciences - Department of Medical Oncology, Central South University - Hunan Cancer Hospital, Chinese Academy of Medical Sciences - Peking Union Medical College, Jilin University (JLU) - First Affiliated Hospital, Academy of Military Sciences - Academy of Military Medical Sciences, Tianjin Medical University, Hebei Medical University, Peking University - Cancer Hospital and Institute, Huazhong University of Science and Technology (Formerly Tongi Medical University), Jiangsu Cancer Hospital - Department of Medical Oncology, Sun Yat-Sen University (SYSU) Cancer Center - Department of Medical Oncology, Fudan University - Shanghai Cancer Center (FUSCC), Jiangsu Hengrui Medicine Co., Ltd. and Jiangsu Hengrui Medicine Co., Ltd.
Downloads 46 (449,678)
Citation 1

Abstract:

Loading...

Pyrotinib, lapatinib, HER2-positive metastatic breast cancer

2.

A Phase 1b Study of Savolitinib Plus Gefitinib for Patients with EGFR-Mutated MET-Amplified Advanced Non-Small-Cell Lung Cancer

Number of pages: 40 Posted: 20 Jan 2020
Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute, Beijing Cancer Hospital, Nanjing Medical University - Department of Oncology, Fudan University, Harbin Medical University - Cancer Hospital, Guangzhou Medical University - First Affiliated Hospital, Jilin University (JLU) - First Affiliated Hospital, Government of the People's Republic of China - 307th Hospital, Central South University - Hunan Cancer Hospital, Tongji University - Shanghai Pulmonary Hospital, Soochow University - First Affiliated Hospital, AstraZeneca Pharmaceuticals - United States, AstraZeneca Pharmaceuticals - United States, AstraZeneca Pharmaceuticals - United Kingdom, AstraZeneca Pharmaceuticals - United Kingdom, AstraZeneca Pharmaceuticals - United Kingdom, AstraZeneca Pharmaceuticals - United Kingdom, AstraZeneca Pharmaceuticals - United Kingdom, AstraZeneca Pharmaceuticals - China and Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute
Downloads 24 (557,855)

Abstract:

Loading...

Savolitinib; Gefitinib; EGFR-TKI; NSCLC; China; MET